Ligand Pharmaceuticals Inc (FRA:LGDN)
€ 252 +8 (+3.28%) Market Cap: 5.22 Bil Enterprise Value: 4.92 Bil PE Ratio: 40.11 PB Ratio: 5.94 GF Score: 74/100

Ligand Pharmaceuticals Inc (FRA:LGDN) Transcripts

  • 1